Name | Number of supported studies | Average coverage | |
---|---|---|---|
adipocyte | 10 studies | 65% ± 17% | |
hepatocyte | 6 studies | 66% ± 26% | |
microglial cell | 6 studies | 25% ± 6% | |
endothelial cell | 4 studies | 25% ± 1% | |
glutamatergic neuron | 4 studies | 31% ± 16% | |
type B pancreatic cell | 3 studies | 46% ± 19% | |
enteroendocrine cell | 3 studies | 34% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 53438.75 | 226 / 226 | 98% | 159.46 | 399 / 406 |
kidney | 98% | 6484.52 | 87 / 89 | 80% | 21.94 | 718 / 901 |
pancreas | 97% | 2348.99 | 318 / 328 | 77% | 18.64 | 137 / 178 |
brain | 73% | 2605.86 | 1926 / 2642 | 69% | 6.59 | 488 / 705 |
adrenal gland | 100% | 14379.24 | 258 / 258 | 41% | 13.70 | 95 / 230 |
intestine | 54% | 2125.16 | 525 / 966 | 87% | 27.80 | 458 / 527 |
thymus | 62% | 1133.11 | 402 / 653 | 66% | 8.76 | 401 / 605 |
ovary | 29% | 503.06 | 52 / 180 | 71% | 14.67 | 305 / 430 |
breast | 85% | 8654.02 | 391 / 459 | 14% | 1.22 | 152 / 1118 |
adipose | 99% | 11737.10 | 1189 / 1204 | 0% | 0 | 0 / 0 |
muscle | 95% | 5817.25 | 766 / 803 | 0% | 0 | 0 / 0 |
stomach | 13% | 238.72 | 46 / 359 | 73% | 23.12 | 209 / 286 |
esophagus | 38% | 746.15 | 553 / 1445 | 44% | 9.72 | 80 / 183 |
lung | 21% | 285.71 | 124 / 578 | 24% | 3.44 | 278 / 1155 |
bladder | 10% | 120.86 | 2 / 21 | 32% | 7.50 | 163 / 504 |
prostate | 22% | 345.90 | 55 / 245 | 4% | 0.31 | 22 / 502 |
uterus | 5% | 139.12 | 8 / 170 | 17% | 3.01 | 78 / 459 |
skin | 17% | 294.86 | 312 / 1809 | 3% | 0.28 | 16 / 472 |
blood vessel | 13% | 455.36 | 168 / 1335 | 0% | 0 | 0 / 0 |
heart | 8% | 137.98 | 69 / 861 | 0% | 0 | 0 / 0 |
spleen | 0% | 48.18 | 1 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 2.48 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0097009 | Biological process | energy homeostasis |
GO_0070328 | Biological process | triglyceride homeostasis |
GO_0055089 | Biological process | fatty acid homeostasis |
GO_0000432 | Biological process | positive regulation of transcription from RNA polymerase II promoter by glucose |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0045723 | Biological process | positive regulation of fatty acid biosynthetic process |
GO_0046889 | Biological process | positive regulation of lipid biosynthetic process |
GO_0008610 | Biological process | lipid biosynthetic process |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0090324 | Biological process | negative regulation of oxidative phosphorylation |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0033137 | Biological process | negative regulation of peptidyl-serine phosphorylation |
GO_0045821 | Biological process | positive regulation of glycolytic process |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0042593 | Biological process | glucose homeostasis |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0010255 | Biological process | glucose mediated signaling pathway |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0035538 | Molecular function | carbohydrate response element binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0001216 | Molecular function | DNA-binding transcription activator activity |
GO_0046982 | Molecular function | protein heterodimerization activity |
Gene name | MLXIPL |
Protein name | Williams-Beuren syndrome chromosome region 14 protein 2 MLX interacting-like protein HCG18989, isoform CRA_h (MLX interacting protein like) Carbohydrate-responsive element-binding protein (ChREBP) (Class D basic helix-loop-helix protein 14) (bHLHd14) (MLX interactor) (MLX-interacting protein-like) (WS basic-helix-loop-helix leucine zipper protein) (WS-bHLH) (Williams-Beuren syndrome chromosomal region 14 protein) MLX interacting protein like |
Synonyms | BHLHD14 MIO WBSCR14 hCG_18989 |
Description | FUNCTION: Binds DNA as a heterodimer with MLX/TCFL4 and activates transcription. Binds to the canonical E box sequence 5'-CACGTG-3'. Plays a role in transcriptional activation of glycolytic target genes. Involved in glucose-responsive gene regulation (By similarity). Regulates transcription in response to changes in cellular carbohydrate abundance such as occurs during fasting to feeding metabolic transition. Refeeding stimulates MLXIPL/ChREBP transcription factor, leading to increased BCKDK to PPM1K expression ratio, phosphorylation and activation of ACLY that ultimately results in the generation of malonyl-CoA and oxaloacetate immediate substrates of de novo lipogenesis and gluconeogenesis, respectively (By similarity). . |
Accessions | S5M7A5 ENST00000429400.6 [Q9NP71-2] ENST00000345114.9 [Q9NP71-5] S5LSP3 ENST00000414749.6 [Q9NP71-3] Q9NP71 ENST00000453275.1 ENST00000354613.5 [Q9NP71-4] ENST00000313375.8 [Q9NP71-1] ENST00000434326.5 C5HU01 C9JDF5 ENST00000456640.2 S5LVX6 H7C1V3 A0A0C4DG26 |